Loading provider…
Loading provider…
Ophthalmology Physician in Crystal City, MO
NPI: 1144316944Primary Practice Location
STE GENEVIEVE COUNTY MEMORIAL HOSPITAL
800 Ste Genevieve Dr, Sainte Genevieve, MO
Primary Employer
Insight Optical
insightoptical.us
HQ Phone
Get MD Humeyra's Phone Numberphone_androidMobile
Get MD Humeyra's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMO State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 92014Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | 432 | 466 |
| 2 | 92012Eye and medical examination for diagnosis and treatment, established patient | 167 | 224 |
| 3 | 92004Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | 145 | 145 |
| 4 | 92134Diagnostic imaging of retina | 140 | 149 |
| 5 | 92136Measurement of corneal curvature and depth of eye | 116 | 176 |
Authors: Carey, Joshua W, Pinarci, Eylem Y, Penugonda, Suman, Karacal, Humeyra, Ercal, Nuran
Journal: Free Radic Biol Med
Publication Date: 2010-12-21
Tofacitinib for refractory uveitis and scleritis.
Authors: Prethy Rao, Michael Paley, Todd Margolis, Jonathan Miner
Journal: Am J Ophthalmol Case Rep
Publication Date: 2018-12-04
The inner diameter of the optic disc pit decreases with pars plana vitrectomy.
Authors: Pinarci, Eylem Yaman, Karacal, Humeyra, Oncel, Banu, Bayar, Sezin Akca, Karakaya, Muharrem
Journal: Int Ophthalmol
Publication Date: 2012-10-31
Lead Sponsor: JHSPH Center for Clinical Trials
Collaborators: National Eye Institute (NEI)
Intervention / Treatment: DRUG: Dexamethasone intravitreal implant 0.7 mg, DRUG: Intravitreal Methotrexate 400 µg, DRUG: Intravitreal Ranibizumab 0.5 mg
Lead Sponsor: JHSPH Center for Clinical Trials
Collaborators: National Eye Institute (NEI)
Intervention / Treatment: DRUG: Periocular triamcinolone 40 mg, DRUG: Intravitreal triamcinolone 4 mg, DRUG: Dexamethasone intravitreal implant